Aeirtec Provides a  Dedicated Service in Sample Biomarker Measurement for BioPharma               

Reducing trial cost and time

Increasing significance of efficacy detection

Our conduct of sample biomarker measurements has demonstrated superior
trial powering for efficacy detection and lower patient number requirements
(Figure 1); confirmed by independent study (1)

Aeirtec’s 20 years experience in clinical trial conduct, analysis and clinical trial
design consultancy provides you with confidence in your Phase I to IV clinical
or preclinical study sample data and reporting

Our integrated immune-inflammatory pharmacology laboratories will also
conduct parallel flow cytometry of your blood samples for cell activation status
and intracellular cytokine production

Benefits and Capacity of our Sample Biomarker Measurement

To discuss your requirements email: info@aeirtec.co.uk

Benefits  and Quality of our Data

Aeirtec’s studies have demonstrated the direct beneficial effect of the number
 of sample replicates that Aeirtec uses on study power for efficacy detection and
the number of subjects required; directly impacting on the success, time  and cost
of your study (figure 1)

Independent studies have demonstrated the problems other testing centres
produce when measuring samples in duplicate or even singlet in which
outliers cannot be detected (Djoba Siawaya JF, et al. (2008))

To derive optimal value from your samples, it is essential that Aeirtec measures
your samples in a minimum of three replicates (figure 1)

Capacity  and  Advice